Classis, participating in the '2025 Korean Laser Dermatology and Hair Society'

Classis Co., Ltd. (CEO Seunghan Baek), a leading company in the global medical aesthetic medical device market, participated in the '2025 Korean Society of Laser Dermatology and Hair Loss Spring International Academic Forum' (hereinafter referred to as DAEPIMO) held at COEX in Samseong-dong on the 11th. At this event, Classis operated a booth exhibiting its representative equipment and shared various treatment solutions, including a total of four lectures and one experience zone demonstration.

At this year’s Spring Academic Conference, Classis exhibited a total of six representative products, including the High-Intensity Focused Ultrasound (HIFU) Shrink Universe, the Monopolar Radiofrequency (MRF) equipment Volnummer, the laser devices Lipot and Curas Hybrid, the Portra that simultaneously irradiates four wavelengths, and the new microneedle radiofrequency (MNRF) equipment scheduled for release in the second half of the year.

The four lectures shared the latest research cases such as EBD mix match and how to improve pigmentation diseases, as well as the experience and know-how of using the Classis equipment. The experience zone received a lot of attention from the visitors with explanations of the actual treatment principles of Repot and equipment exhibitions.

In addition, Classis attracted attention by sharing the latest research cases of the new microneedle radiofrequency (MNRF) equipment scheduled for release in the second half of the year at this conference. It explained the core technology and utilization methods with a focus on the actual treatment environment, and it was an opportunity to collect initial feedback from medical staff to improve the product's perfection and raise expectations for its release.

A Classis official said, “This year’s Daepimo conference was a meaningful opportunity to meet domestic medical professionals in person, introduce our products, and share the latest clinical results,” adding, “We will continue to work closely with medical professionals to develop solutions for both medical professionals and consumers.”

Meanwhile, through its merger with Iruda in 2024, Classis has completed a portfolio encompassing the entire energy-based (EBD) product line, and is carrying out various activities to secure leadership in the global market, such as participating in domestic and international academic events and marketing to consumers.


  • See more related articles